Working closely with healthcare professionals has led to the development of multiple products, seeking to improve the lives of patients with Cystic Fibrosis.
We have ensured that radiographers, gastroenterologists and radiologists, can continue to practice cost effective diagnostics. We are able to do this through securing the continuity of supply of previously available diagnostics which have been discontinued by larger companies.
By keeping the needs of patients with compromised haemostasis in mind, we have developed a commercial product for use in invasive dental procedures.
Patients are highly motivated to protect their ophthalmic health. ParaPharm is passionate about discovering and developing new therapeutic agents to also help protect and preserve vision.
Antibiotic resistance is on the increase1. It is important to protect the utility of the classes that we currently have. We are collaborating with partners on the commercialisation of antibiotic therapies for multi-drug resistant bacteria.
ParaPharm Development Limited ensure adequate stock levels of all our products in the UK supply chain. If you have been informed otherwise, please do not hesitate to contact us directly on telephone +44 (0) 118 221 0150 for further clarification regarding our stock undertaking.
Reference: 1. Ventola CL. The Antibiotic Resistance Crisis Part 1 : Causes and Threats. 2015;40(4):277–83.